Name | Matrix metalloproteinase-13 | ||
UniProt ID | MMP13_HUMAN | ||
Gene Name | MMP13 | ||
Gene ID | 4322 | ||
Synonyms |
MMP13, CLG3, MANDP1, MDST, MMP-13
|
||
Sequence |
MHPGVLAAFLFLSWTHCRALPLPSGGDEDDLSEEDLQFAERYLRSYYHPTNLAGILKENA
ASSMTERLREMQSFFGLEVTGKLDDNTLDVMKKPRCGVPDVGEYNVFPRTLKWSKMNLTY RIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDG PSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALM FPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGET MIFKDRFFWRLHPQQVDAELFLTKSFWPELPNRIDAAYEHPSHDLIFIFRGRKFWALNGY DILEGYPKKISELGLPKEVKKISAAVHFEDTGKTLLFSGNQVWRYDDTNHIMDKDYPRLI EEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPANSILWC |
||
Pathway Map | MAP LINK | ||
KEGG ID | hsa4322 | ||
TTD ID | T34296 | ||
Pfam | PF00045; PF00413; PF01471; PF13582; PF13583; PF13688; PF16313 |
Pair Name | Paeoniflorin, Talatizidine | |||
Phytochemical | Paeoniflorin | |||
Drug | Talatizidine | |||
Disease Info | [ICD-11: FA20] | Rheumatoid arthritis | Investigative | |
Regulate Info | Up-regulation | Matrix metalloproteinase-13 | Expression | |
Result | This study identified PAE and TLT as the main BACs of WTD in alleviating the severity of RA, and also developed a novel combination of PAE and TLT as a promising candidate drug for RA therapy. |